Robyn D. Gartrell

2.7k citations

45 papers · 842 indexed · h-index 18

Impact in

Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Immunology top 10%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Cell Function and Interaction

Papers in

Genetics 14
- Glioma Diagnosis and Treatment 13
- Virus-based gene therapy research 6
Oncology 23
- Cancer Immunotherapy and Biomarkers 14
- CAR-T cell therapy research 6
- Cutaneous Melanoma Detection and Management 4

Co-authors: Yvonne M. Saenger Emanuelle M. Rizk Thomas D. Hart Bret Taback Raúl Rabadán Zoë Blake Luke W. Barker Andrew Chen
Journals: Journal of Clinical Oncology (5 papers)Journal for ImmunoTherapy of Cancer (4 papers)Neuro-Oncology (3 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)Clinical Cancer Research (2 papers)
Partner nations: United States Canada Netherlands

In The Last Decade

Robyn D. Gartrell

39 papers receiving 836 citations

Peers

Countries citing papers authored by Robyn D. Gartrell

Since Specialization

Citations

This map shows the geographic impact of Robyn D. Gartrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robyn D. Gartrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robyn D. Gartrell more than expected).

Fields of papers citing papers by Robyn D. Gartrell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robyn D. Gartrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robyn D. Gartrell. The network helps show where Robyn D. Gartrell may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Robyn D. Gartrell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robyn D. Gartrell Line = papers co-authored together Robyn D. Gartrell links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Combined inhibition of SHP2 overcomes adaptive resistance to type 1 BRAF inhibitors in BRAF V600E-driven high-grade glioma Neuro-Oncology Advances ·Kastriot A. Buza, Michael Chang, سارا خداوردیان, Wasit Dirgantara, Jiawan Wang, F. Li, Yanbo Yang, Calixto‐Hope G. Lucas, Jean M. Mulcahy Levy, Robyn D. Gartrell, Christine A. Pratilas, Karisa C. Schreck	2025	0
2	One-Two Punch: Combining Chemotherapy and Immunotherapy to Decrease Radiation Dose and Related Toxicity in Children and Adolescents with Nasopharyngeal Carcinoma Clinical Cancer Research ·Hetal Dholaria, Patricio Gerardo Salgado-Arias, Stephen T. Simpson, 顾忠安, R. G. Bevan, Carlos Rodríguez‐Galindo, Kris Ann P. Schultz, Kenneth Chen, Cheng–Chia Wu, Matthew J. Krasin, M. Ralska, Hans Christiansen, Jin Piao, Theodore W. Laetsch, Farzana Pashankar, Udo Kontny, Robyn D. Gartrell	2025	0
3	Multimodal analysis of pediatric pilocytic astrocytomas reveals tumor location-associated cellular and transcriptional heterogeneity Neuro-Oncology ·Sergej Kalendzhjan, Luiz Mauro Andrade Fonseca, Friso Calkoen, 太計佐藤, 一志黒谷, Tiago Carvalheiro, Aressa Egly Silveira, Robyn D. Gartrell, Dannis G van Vuurden, Henk G. Stunnenberg, Eelco W. Hoving, Pieter Wesseling, Jasper van der Lugt, Mariëtte E.G. Kranendonk, Lennart Kester	2025	1
4	Focused ultrasound-mediated blood–brain barrier opening is safe and feasible with moderately hypofractionated radiotherapy for brainstem diffuse midline glioma Journal of Translational Medicine ·André Luiz Martins, Susanne Bitzer, Hong-Jian Wei, Matthew Gallitto, Feyza Özdemir Kısacık, ابوالفضل خلخالی, 拜庆平, David Chouman, Xu Zhang, Zhiguo Zhang, Chia‐Ing Jan, Akiva Mintz, Robyn D. Gartrell, Mohd Zaid Abdul Kadir, Adriana Fonseca, Davis Nutridemics International Food Policy Research Institute University Of California, Luca Szalontay, Elisa E. Konofagou, Stergios Zacharoulis, Cheng–Chia Wu	2024	14
5	Children's Oncology Group's 2023 blueprint for research: Rare tumors Pediatric Blood & Cancer ·Kris Ann P. Schultz, Murali Chintagumpala, Jin Piao, Kenneth Chen, Robyn D. Gartrell, Emily Christison‐Lagay, Jesse L. Berry, Rachana Shah, Theodore W. Laetsch	2023	3
6	Combining immunotherapy with high-dose radiation therapy (HDRT) significantly inhibits tumor growth in a syngeneic mouse model of high-risk neuroblastoma Heliyon ·Wu Haoxi, Shunsaku Horiuchi, Debarshi Banerjee, A Zavers, Robert Parzer, Kuczala Zj, Androniki D. Sotiriadou, Robyn D. Gartrell, Yvonne M. Saenger, David Welch, Cheng–Chia Wu, Angela V. Kadenhe‐Chiweshe, Darrell J. Yamashiro, Eileen P. Connolly	2023	4
7	DIPG-49. A SYSTEMS BIOLOGY APPROACH TO DEFINING AND TARGETING CELL STATE-SPECIFIC MASTER REGULATOR DEPENDENCIES IN DIFFUSE MIDLINE GLIOMA Neuro-Oncology ·William Bowtell, Junqiang Wang, Xu Zhang, Hong-Jian Wei, ルドルフシュトラインツ, Aaron T. Griffin, Aleksandar Obradović, Lukas Vlahos, Timothy J. Martins, Pamela S. Becker, John Crawford, Robyn D. Gartrell, Luca Szalontay, Stergios Zacharoulis, Zhiguo Zhang, Robert J. Wechsler‐Reya, Cheng–Chia Wu, Andrea Califano, Davis Nutridemics International Food Policy Research Institute University Of California	2023	0
8	Rare tumors: Opportunities and challenges from the Children’s Oncology Group perspective SHILAP Revista de lepidopterología ·Kris Ann P. Schultz, Murali Chintagumpala, Jin Piao, Kenneth Chen, Rachana Shah, Robyn D. Gartrell, Emily Christison‐Lagay, Я. С. Горбунова, Jesse L. Berry, Allison F. O’Neill, F. P. U. Croker, Daryl Kubilus, Teresa L. Lutes, Xiaowei Pan, Jeremy Rosenblum, Ida Lukmana, Junne Kamihara, Carlos Rodríguez‐Galindo, Douglas S. Hawkins, Theodore W. Laetsch	2023	4
9	Exploiting Radiation Therapy to Restore Immune Reactivity of Glioblastoma Frontiers in Oncology ·Mara De Martino, Cutler Dl, 권오열, Cheng–Chia Wu, Robyn D. Gartrell, Claire Vanpouille‐Box	2021	12
10	Transcriptomic analysis identifies differences in gene expression in actinic keratoses after treatment with imiquimod and between responders and non responders Scientific Reports ·Megan H. Trager, Emanuelle M. Rizk, Sharon Rose, Kuixi Zhu, Zuliang Wang, ST Hidayat, Juan eacute, Michael Moore, Jocabel Extocapan Molina, Giselle Singer, Robyn D. Gartrell, Rui Chang, Larisa J. Geskin, Yvonne M. Saenger, Gary Goldenberg	2021	2
11	Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma Cancer Research ·Robyn D. Gartrell, Andrew Chen, Emanuelle M. Rizk, Douglas K. Marks, Catrin Bernius, Thomas D. Hart, Andrew M. Silverman, Sari Apriliana R, 圭祐米原, Luke W. Barker, Kimberly M. Komatsubara, Richard D. Carvajal, Basil A. Horst, Rui Chang, Т. Ю. Попик, Raúl Rabadán, Yvonne M. Saenger	2020	17
12	Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer Frontiers in Oncology ·Douglas K. Marks, Robyn D. Gartrell, Margueritta El Asmar, Wu Haoxi, Thomas D. Hart, Yan Lu, Qingfei Pan, Jiyang Yu, Hanina Hibshoosh, Hua Guo, Eleni Andreopoulou, Lisa Wiechmann, Katherine D. Crew, Joseph A. Sparano, Dawn L. Hershman, Eileen P. Connolly, Yvonne M. Saenger, Kevin Kalinsky	2020	20
13	Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition Journal for ImmunoTherapy of Cancer ·Jared M. Newton, Кирикова Ольга Алексеевна, Hsuan‐Chen Liu, Murali Krishna Boddu, Falguni Parikh, Robyn D. Gartrell, Thomas D. Hart, Damya Laoui, Jo A. Van Ginderachter, Neeraja Dharmaraj, William C. Spanos, Yvonne M. Saenger, Simon Young, Andrew G. Sikora	2019	63
14	Prognostic and Predictive Immunohistochemistry-Based Biomarkers in Cancer and Immunotherapy Hematology/Oncology Clinics of North America ·Emanuelle M. Rizk, Robyn D. Gartrell, Luke W. Barker, 学校経営法令研究会, 圭祐米原, Darius Bordbar, Yvonne M. Saenger	2019	26
15	An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma Nature Communications ·Balázs Ács, Fahad Shabbir Ahmed, Swati Gupta, Pok Fai Wong, Robyn D. Gartrell, Juan eacute, Emanuelle M. Rizk, Bonnie Gould Rothberg, Yvonne M. Saenger, David L. Rimm	2019	64
16	1192 Distinguishing melanophages from melanoma in metastatic melanoma treated with t-vec: A clinical application of quantitative multiplex immunofluorescence Journal of Investigative Dermatology ·Sari Apriliana R, Robyn D. Gartrell, Jamaliah Jamari, Juan eacute, Han Yun-Cheng, Zoë Blake, Douglas K. Marks, George Niedt, Basil A. Horst, Larisa J. Geskin, Yvonne M. Saenger	2018	2
17	Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition Journal for ImmunoTherapy of Cancer ·Zoë Blake, Douglas K. Marks, Robyn D. Gartrell, Thomas D. Hart, Fletcher W. James, Simon K. Cheng, Bret Taback, Basil A. Horst, Yvonne M. Saenger	2018	29
18	Disease stabilization with pembrolizumab for metastatic acral melanoma in the setting of autoimmune bullous pemphigoid Journal for ImmunoTherapy of Cancer ·Kevina McGarry, Joanna Dong, Larisa J. Geskin, Amanda K. Small, Richard G. Phelps, Richard D. Carvajal, Gary K. Schwartz, Yvonne M. Saenger, Robyn D. Gartrell	2016	32
19	Talimogene laherparepvec (T-Vec) for the treatment of melanoma and other cancers Seminars in Oncology ·Claud Grigg, Zoë Blake, Robyn D. Gartrell, Adrian G. Sacher, Bret Taback, Yvonne M. Saenger	2016	51
20	Timing of Adjuvant Radiotherapy in Glioblastoma Patients Neurosurgery ·Tony J. C. Wang, A. Jani, 洋一中西, Timothy H. Ung, Daniel Chow, Jennifer E. Soun, S. B. Kim, Brahim Nasry, Robyn D. Gartrell, Steven R. Isaacson, Simon K. Cheng, Guy M. McKhann, Jeffrey N. Bruce, Andrew B. Lassman, Michael B. Sisti	2015	27

About Robyn D. Gartrell

Robyn D. Gartrell is a scholar working on Genetics, Oncology, Immunology, Hepatology and Genetics, having authored 45 papers that have together received 842 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Glioma Diagnosis and Treatment (13 papers), Immunotherapy and Immune Responses (12 papers), Virus-based gene therapy research (6 papers), CAR-T cell therapy research (6 papers), Cutaneous Melanoma Detection and Management (4 papers), Nanoplatforms for cancer theranostics (4 papers) and Immune cells in cancer (4 papers). The work is most often cited by research in Oncology (472 citations), Immunology (297 citations), Genetics (103 citations), Cancer Research (90 citations) and Radiology, Nuclear Medicine and Imaging (116 citations). Robyn D. Gartrell has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Yvonne M. Saenger, Emanuelle M. Rizk, Thomas D. Hart, Bret Taback, Raúl Rabadán, Zoë Blake, Luke W. Barker, Andrew Chen, Douglas K. Marks and Adrian G. Sacher. Their work appears in journals such as Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer, Neuro-Oncology, International Journal of Radiation Oncology*Biology*Physics and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact